| 2XP6 | A:51-163 | DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION |
| 3O5E | A: | FK1 DOMAIN OF FKBP51, CRYSTAL FORM VI |
| 3O5F | A: | FK1 DOMAIN OF FKBP51, CRYSTAL FORM VII |
| 3O5G | A: | FK1 DOMAIN OF FKBP51, CRYSTAL FORM I |
| 3O5I | A:; B: | FK1 DOMAIN OF FKBP51, CRYSTAL FORM II |
| 3O5J | A: | FK1 DOMAIN OF FKBP51, CRYSTAL FORM III |
| 3O5K | A:; B:; C:; D: | FK1 DOMAIN OF FKBP51, CRYSTAL FORM VIII |
| 3O5L | A: | FK1 DOMAIN MUTANT A19T OF FKBP51, CRYSTAL FORM I |
| 3O5M | A:; B: | FK1 DOMAIN MUTANT A19T OF FKBP51, CRYSTAL FORM II |
| 3O5O | A: | FK1 DOMAIN MUTANT A19T OF FKBP51, CRYSTAL FORM III |
| 3O5P | A: | FK1 DOMAIN MUTANT A19T OF FKBP51, CRYSTAL FORM IV |
| 3O5Q | A: | FK1 DOMAIN MUTANT A19T OF FKBP51, CRYSTAL FORM IV, IN PRESENCE OF DMSO |
| 3O5R | A: | COMPLEX OF FK506 WITH THE FK1 DOMAIN MUTANT A19T OF FKBP51 |
| 3UI4 | A: | 0.8 A RESOLUTION CRYSTAL STRUCTURE OF HUMAN PARVULIN 14 |
| 3UI5 | A: | CRYSTAL STRUCTURE OF HUMAN PARVULIN 14 |
| 3UI6 | A: | 0.89 A RESOLUTION CRYSTAL STRUCTURE OF HUMAN PARVULIN 14 IN COMPLEX WITH OXIDIZED DTT |
| 4DRH | A:; D: | CO-CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF FKBP51, RAPAMYCIN AND THE FRB FRAGMENT OF MTOR AT LOW PH |
| 4DRI | A: | CO-CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF FKBP51, RAPAMYCIN AND THE FRB FRAGMENT OF MTOR |
| 4DRK | A:; B: | EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[(1R)-3-(3,4-DIMETHOXYPHENYL)-1-({[(2S)-1-(3,3-DIMETHYL-2-OXOPENTANOYL)PIPERIDIN-2-YL]CARBONYL}OXY) PROPYL]PHENOXY}ACETIC ACID |
| 4DRM | A: | EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[(1R)-3-(3,4-DIMETHOXYPHENYL)-1-({[(2S)-1-{[(1S,2R)-2-ETHYL-1-HYDROXYCYCLOHEXYL](OXO) ACETYL}PIPERIDIN-2-YL]CARBONYL}OXY)PROPYL]PHENOXY}ACETIC ACID |
| 4DRN | A: | EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[(1R)-3-(3,4-DIMETHOXYPHENYL)-1-({[(2S)-1-{[(1S,2R)-2-ETHYL-1-HYDROXYCYCLOHEXYL](OXO) ACETYL}PIPERIDIN-2-YL]CARBONYL}OXY)PROPYL]PHENOXY}ACETIC ACID |
| 4DRO | A: | EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH (1R)-3-(3,4-DIMETHOXYPHENYL)-1-PHENYLPROPYL (2S)-1-{[(1R,2S)-2-ETHYL-1-HYDROXYCYCLOHEXYL](OXO) ACETYL}PIPERIDINE-2-CARBOXYLATE |
| 4DRP | A: | EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR THE FK506-BINDING PROTEINS 51 AND 52: COMPLEX OF FKBP51 WITH 2-(3-((R)-3-(3,4-DIMETHOXYPHENYL)-1-((S)-1-(2-((1R,2S)-2-ETHYL-1-HYDROXY-CYCLOHEXYL)-2-OXOACETYL)PIPERIDINE-2-CARBONYLOXY)PROPYL)PHENOXY)ACETIC ACID FROM COCRYSTALLIZATION |
| 4DRQ | A: | EXPLORATION OF PIPECOLATE SULFONAMIDES AS BINDERS OF THE FK506-BINDING PROTEINS 51 AND 52: COMPLEX OF FKBP51 WITH 2-(3-((R)-1-((S)-1-(3,5-DICHLOROPHENYLSULFONYL)PIPERIDINE-2-CARBONYLOXY)-3-(3,4-DIMETHOXY - PHENYL)PROPYL)PHENOXY)ACETIC ACID |
| 4IQ2 | A:; B: | P21 CRYSTAL FORM OF FKBP12.6 |
| 4IQC | A:; B: | P3121 CRYSTAL FORM OF FKBP12.6 |
| 4JFI | A: | INCREASING THE EFFICIENCY EFFICIENCY OF LIGANDS FOR THE FK506-BINDING PROTEIN 51 BY CONFORMATIONAL CONTROL: COMPLEX OF FKBP51 WITH COMPOUND 1-[(9S,13R,13AR)-1,3-DIMETHOXY-8-OXO-5,8,9,10,11,12,13,13A-OCTAHYDRO-6H-9,13-EPIMINOAZOCINO[2,1-A]ISOQUINOLIN-14-YL]-2-(3,4,5-TRIMETHOXYPHENYL)ETHANE-1,2-DIONE |
| 4JFJ | A: | INCREASING THE EFFICIENCY EFFICIENCY OF LIGANDS FOR THE FK506-BINDING PROTEIN 51 BY CONFORMATIONAL CONTROL: COMPLEX OF FKBP51 WITH COMPOUND (1S,6R)-10-(1,3-BENZOTHIAZOL-6-YLSULFONYL)-3-[2-(3,4-DIMETHOXYPHENOXY)ETHYL]-3,10-DIAZABICYCLO[4.3.1]DECAN-2-ONE |
| 4JFK | A: | INCREASING THE EFFICIENCY EFFICIENCY OF LIGANDS FOR THE FK506-BINDING PROTEIN 51 BY CONFORMATIONAL CONTROL: COMPLEX OF FKBP51 WITH (1S,6R)-3-[2-(3,4-DIMETHOXYPHENOXY)ETHYL]-10-[(2-OXO-2,3-DIHYDRO-1,3-BENZOTHIAZOL-6-YL)SULFONYL]-3,10-DIAZABICYCLO[4.3.1]DECAN-2-ONE |
| 4JFL | A: | INCREASING THE EFFICIENCY EFFICIENCY OF LIGANDS FOR THE FK506-BINDING PROTEIN 51 BY CONFORMATIONAL CONTROL: COMPLEX OF FKBP51 WITH 6-({(1S, 5R)-3-[2-(3,4-DIMETHOXYPHENOXY)ETHYL]-2-OXO-3,9-DIAZABICYCLO[3.3.1]NON-9-YL}SULFONYL)-1,3-BENZOTHIAZOL-2(3H)-ONE |
| 4JFM | A: | INCREASING THE EFFICIENCY EFFICIENCY OF LIGANDS FOR THE FK506-BINDING PROTEIN 51 BY CONFORMATIONAL CONTROL: COMPLEX OF FKBP51 WITH 2-(3,4-DIMETHOXYPHENOXY)ETHYL (2S)-1-[(2-OXO-2,3-DIHYDRO-1,3-BENZOTHIAZOL-6-YL)SULFONYL]PIPERIDINE-2-CARBOXYLATE |
)
)